Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewIT1t dihydrochloride is a potent CXCR4 antagonist (IC50 = 1.1 nM in calcium mobilization assays). Orally available. Blocks interaction with the HIV envelope protein, gp120 (IC50 = 7 nM, inhibition of X4-tropic HIV-1IIIB attachment).
M. Wt | 479.57 |
Formula | C21H34N4S2.2HCl |
Storage | Store at +4°C |
Purity | ≥99% (HPLC) |
CAS Number | 1092776-63-0 |
PubChem ID | 25178351 |
InChI Key | HFXJOXOIINQOEB-UHFFFAOYSA-N |
Smiles | CC1(C)CN(C(CS/C(NC4CCCCC4)=N/C3CCCCC3)=CS2)C2=N1.Cl.Cl |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 4.8 | 10 | |
water | 47.96 | 100 |
The following data is based on the product molecular weight 479.57. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.09 mL | 10.43 mL | 20.85 mL |
5 mM | 0.42 mL | 2.09 mL | 4.17 mL |
10 mM | 0.21 mL | 1.04 mL | 2.09 mL |
50 mM | 0.04 mL | 0.21 mL | 0.42 mL |
References are publications that support the biological activity of the product.
Thoma et al (2008) Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo. J.Med.Chem. 51 7915 PMID: 19053768
If you know of a relevant reference for IT1t dihydrochloride, please let us know.
Keywords: IT1t dihydrochloride, IT1t dihydrochloride supplier, CXCR4, antagonists, HIV, envelope, protein, gp120, chemokines, receptors, type, 4, Chemokine, CXC, Receptors, 4596, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for IT1t dihydrochloride include:
White et al (2020) CRISPR-Mediated Protein Tagging with Nanoluciferase to Investigate Native Chemokine Receptor Function and Conformational Changes. Cell Chem Bio PMID: 32053779
Mathias et al (2021) Cell surface thermal proteome profiling tracks perturbations and drug targets on the plasma membrane. Nat Methods 18 84-91 PMID: 33398190
Smith et al (2019) Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment. Sci Adv 5 eaav9019 PMID: 31309143
Yung-Chi et al (2019) Characterization, Dynamics, and Mechanism of CXCR4 Antagonists on a Constitutively Active Mutant. Cell Chem Biol 26 662-673.e7 PMID: 30827936
Martin J et al (2020) Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4. Mol Pharmacol 98 72-87 PMID: 32474443
Ludger et al (2020) Microtiter plate-based antibody-competition assay to determine binding affinities and plasma/blood stability of CXCR4 ligands. Sci Rep 10 16036 PMID: 32994431
Martine J et al (2020) Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies. Cell Chem Biol 27 1250-1261.e5 PMID: 32610042
Do you know of a great paper that uses IT1t dihydrochloride from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review IT1t dihydrochloride and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune disease that results from a breakdown in immune tolerance, for reasons that are as yet unknown. This poster summarizes the pathology of RA and the inflammatory processes involved, as well as describing some of the epigenetic modifications associated with the disease and the potential for targeting these changes in the discovery of new treatments.